ChemMedChem最新文献

筛选
英文 中文
Synthesis, Moleculer Modeling, and Carbonic Anhydrase Inhibitor Effects of Novel 1-(1-benzyl-2-oxoindolin-3-ylidene)-4-(3-sulfamoylphenyl)thiosemicarbazides 新型1-(1-苄基-2-氧吲哚-3-酰基)-4-(3-磺胺基苯基)硫代氨基脲的合成、分子模拟及碳酸酐酶抑制剂作用
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-12 DOI: 10.1002/cmdc.70467
Çağla Begüm Apaydın, Tuğçe Cinek, Hayrunnisa Nadaroğlu, Nilgün Karalı
{"title":"Synthesis, Moleculer Modeling, and Carbonic Anhydrase Inhibitor Effects of Novel 1-(1-benzyl-2-oxoindolin-3-ylidene)-4-(3-sulfamoylphenyl)thiosemicarbazides","authors":"Çağla Begüm Apaydın,&nbsp;Tuğçe Cinek,&nbsp;Hayrunnisa Nadaroğlu,&nbsp;Nilgün Karalı","doi":"10.1002/cmdc.70467","DOIUrl":"10.1002/cmdc.70467","url":null,"abstract":"<p>In this study, we describe the synthesis of new 1-(1-benzyl-2-oxoindolin-3-ylidene)-4-(3-sulfamoylphenyl)thiosemicarbazides and evaluate their inhibitory activity against hCAs (<b>6a–l</b>). The inhibitory effects of compounds <b>6a–l</b> were examined in vitro against hCA I, II, IX, and XII isoforms. Acetazolamide (AAZ) was employed as the standard reference compound in this study. The compounds <b>6a–l</b> inhibited the tumor-associated hCA IX and XII isoenzymes at nanomolar levels, and showed weak inhibitory effects on the off-target hCA I and II isoenzymes. Selectivity index (SI) values of compounds <b>6a–l</b> were determined to be significantly high for hCA IX and XII over hCA I and II compared to AAZ. Compound <b>6k</b> (R<sub>1</sub> = Cl, R<sub>2</sub> = 3-Cl) showed the strongest inhibitory effect (<i>K</i><sub><i>i</i></sub> = 25.23 nM) and high selectivity (SI = 225, 185) against hCA IX over hCA I and II. Compound <b>6f</b> (R<sub>1</sub> = CH<sub>3</sub>, R<sub>2</sub> = 4-Cl) was found to have the highest inhibitory effect (<i>K</i><sub><i>i</i></sub> = 36.65 nM) and high selectivity (SI = 377 and 192, respectively) against hCA XII over hCA I and II. Molecular docking and dynamic simulation analyses were conducted to explore how compounds <b>6f</b> and <b>6k</b> interact with active sites of hCA XII and IX enzymes.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149163368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network Pharmacology in Drug Discovery: Current Advances, Challenges, and Future Directions Toward Precision Medicine 网络药理学在药物发现:目前的进展,挑战和未来的方向,以精确医学。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-12 DOI: 10.1002/cmdc.70526
Kuttiappan Anitha, Santenna Chenchula, Shubham Subhash Kumar Sharma, Chavan Aditya, Gaurav Paraskar
{"title":"Network Pharmacology in Drug Discovery: Current Advances, Challenges, and Future Directions Toward Precision Medicine","authors":"Kuttiappan Anitha,&nbsp;Santenna Chenchula,&nbsp;Shubham Subhash Kumar Sharma,&nbsp;Chavan Aditya,&nbsp;Gaurav Paraskar","doi":"10.1002/cmdc.70526","DOIUrl":"10.1002/cmdc.70526","url":null,"abstract":"<p>Network pharmacology (NP) is an innovative drug discovery method that provides a comprehensive view of drug–body interactions through complex biological networks. Each drug modulates specific network nodes, and understanding these interactions helps predict therapeutic effects and side effects. By integrating diverse data types and advanced computational methods, NP enables more accurate identification of new drug targets, accelerating the development of effective, targeted therapies. It also supports personalized medicine by tailoring treatments to individual biological profiles. This review examines the fundamentals and strategic significance of NP in drug discovery. Network-based approaches unravel complex molecular interactions and discover drug targets with high accuracy. Holistic NP implementation integrates omics datasets and computational tools to deliver actionable insights. The difficulty of screening all drug pairs due to time and cost constraints has driven the development of computational methods to predict side effects efficiently. NP holds transformative potential for precision medicine, promising improved patient outcomes and innovative treatments across many diseases. Conclusively, NP is transforming drug discovery by providing a whole-view approach to drug interactions and enabling effective, personalized therapeutic interventions.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Limiting Trial-and-Error: Linker-Based 2D Descriptor Analysis to Support Very Early Proteolysis-Targeting Chimeras Design 限制试错:基于链接的二维描述子分析,以支持非常早期的蛋白水解靶向嵌合体设计。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-11 DOI: 10.1002/cmdc.70532
Giulia Apprato, Serena Traversa, Giulia Caron, Giuseppe Ermondi
{"title":"Limiting Trial-and-Error: Linker-Based 2D Descriptor Analysis to Support Very Early Proteolysis-Targeting Chimeras Design","authors":"Giulia Apprato,&nbsp;Serena Traversa,&nbsp;Giulia Caron,&nbsp;Giuseppe Ermondi","doi":"10.1002/cmdc.70532","DOIUrl":"10.1002/cmdc.70532","url":null,"abstract":"<p>Targeted protein degradation has emerged as a clinically validated therapeutic strategy, culminating in the recent FDA approval of the first proteolysis-targeting chimeras (PROTAC) drug (VEPPANU). Within PROTACs, the linker plays a central role in modulating degradation efficiency as well as physicochemical and in vitro absorption, distribution, metabolism, and excretion properties, yet linker optimization still largely relies on empirical “linkerology” approaches. Here, we investigated whether simple 2D linker descriptors could provide informative insights for very early-stage PROTAC design. Four matched PROTAC series, including both cereblon- and von Hippel–Lindau-recruiting degraders, were retrospectively analyzed using a workflow combining the in-house Bellerophon-based linker extraction with principal component analysis. Selected descriptors captured linker hydrophobicity, polarity, flexibility, and topology and were correlated with experimental degradation, permeability, solubility, lipophilicity, protein binding, and metabolic stability data. In several datasets, linker-dependent trends associated with the molecular properties of degraders and their degradation efficiency were identified, particularly for von Hippel–Lindau-based PROTACs. Although the limited size of currently available datasets prevents broad generalization, this work highlights the potential of simple descriptor-based analyses to support early candidate prioritization and reduce unnecessary synthetic efforts.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanozymes in Action: Inbuilt Asymmetric Local Electric Field for Enhanced Ferroptosis-Pyroptosis Therapy 纳米酶的作用:内置不对称局部电场增强焦铁-焦亡治疗。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-11 DOI: 10.1002/cmdc.70500
Huidrom Mangalsana, Aswin P., Amit A. Vernekar
{"title":"Nanozymes in Action: Inbuilt Asymmetric Local Electric Field for Enhanced Ferroptosis-Pyroptosis Therapy","authors":"Huidrom Mangalsana,&nbsp;Aswin P.,&nbsp;Amit A. Vernekar","doi":"10.1002/cmdc.70500","DOIUrl":"10.1002/cmdc.70500","url":null,"abstract":"<p>Conventional nanozymes are generally reported to have a symmetric coordination environment near the active centers that can hinder electron transfer and result in limited catalytic efficiency. In a recent article by Na Na and colleagues, an axial sulfur-bridged Mo–S–Cu (A-CuN<sub>3</sub>S<sub>1</sub>@MoS<sub>2−<i>x</i></sub>) nanozyme is developed that functions by utilizing an expanded asymmetric local electric field (LEF). The innovative structure significantly ramps up multienzymatic activities, which include catalase-, peroxidase-, and oxidase-like functions, while concomitantly depleting glutathione. As this nanozyme specifically targets mitochondria in tumors, it initiates a cascade of reactive oxygen species (ROS), activating combined ferroptosis and gasdermin E (GSDME)-mediated pyroptosis. We highlight these findings on how the axial-bridging strategy offers a sophisticated design for nonapoptotic tumor therapy through the modalities of coordination chemistry and electronic structure modulation.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149163570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of Substituted Indazoles With Potential Kinase Inhibitory Activity 具有潜在激酶抑制活性的取代茚唑的合成。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-08 DOI: 10.1002/cmdc.70522
Achraf Hibot, Abderrafia Hafid, Mostafa Khouili, Maria Dolors Pujol
{"title":"Synthesis of Substituted Indazoles With Potential Kinase Inhibitory Activity","authors":"Achraf Hibot,&nbsp;Abderrafia Hafid,&nbsp;Mostafa Khouili,&nbsp;Maria Dolors Pujol","doi":"10.1002/cmdc.70522","DOIUrl":"10.1002/cmdc.70522","url":null,"abstract":"<p>In this work, a versatile and efficient synthetic strategy for the selective <i>N</i>-1 alkylation of nitro-substituted 3-haloindazoles was developed using a complex base of NaH/<i>t</i>-BuOK. Various alkylating agents were employed under an argon atmosphere in DMF. This method successfully yielded several <i>N</i>-1-alkylated indazole derivatives, including 1-benzyl-3-chloro-6-nitro-1<i>H</i>-indazole, 1-benzyl-3-bromo-6-nitro-1<i>H</i>-indazole, and related analogs, with good to excellent yields (62%–100%). Subsequent amination reactions of the 3-bromoindazole intermediates with anilines provided <i>N</i>-arylindazoles at the C-3 position in moderate yields (11%–70%). In parallel, Suzuki–Miyaura cross-coupling reactions with boronic acids provided direct access to arylindazoles at the C-3 position with yields ranging from 54% to 92%. Of the compounds evaluated biologically, <b>16</b> and <b>18c</b> stand out, having shown high inhibition of CDK2 (100% at 10 μM), while <b>13e</b> and <b>16</b> showed maximum inhibition of ERK2 (100% at 10 μM), both proteins implicated in cancer.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149134507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ti(IV) Asymmetric Acetyl-Substituted Phenolato Hexacoordinate Complexes as Anticancer Chemotherapy of Enhanced Bioavailability 不对称乙酰取代苯酚六配位配合物作为提高生物利用度的抗癌化疗药物。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-08 DOI: 10.1002/cmdc.70519
Mohammad Taha, Anwesh Pandey, Avital Shurki, Edit Y. Tshuva
{"title":"Ti(IV) Asymmetric Acetyl-Substituted Phenolato Hexacoordinate Complexes as Anticancer Chemotherapy of Enhanced Bioavailability","authors":"Mohammad Taha,&nbsp;Anwesh Pandey,&nbsp;Avital Shurki,&nbsp;Edit Y. Tshuva","doi":"10.1002/cmdc.70519","DOIUrl":"10.1002/cmdc.70519","url":null,"abstract":"<p>A series of four titanium(IV) complexes based on asymmetric diaminobis(phenolato)-bis(alkoxo) ligands with different substitutions and acetyl functional groups was synthesized and characterized. All complexes were analyzed by <sup>1</sup>H NMR,<sup>13</sup>C NMR, and HRMS. Three complexes were analyzed by X-ray crystallography; interestingly, whereas two complexes were similar to previously published structures showing <i>C</i><sub>1</sub> asymmetrical mononuclear octahedral coordination sphere, one structure of a bulky iodinated complex indicated formation of a unique pseudo-<i>C</i><sub>2</sub> symmetrical hepta-coordinated dimer, where computational studies indicated mostly subtle solvent and temperature effects. High hydrolytic stability was recorded for all derivatives, with <i>t</i><sub>½</sub> of more than 3 days for hydrolysis in 10% D<sub>2</sub>O organic solutions, with enhanced solubility in PBS/DMSO (up to 0.25 mg/mL in &lt;0.5% DMSO aqueous solution). All complexes were highly cytotoxic toward human ovarian A2780 and colon HT-29 cancer cell lines (IC<sub>50</sub> values in the range of 0.5–10 µM). Cellular uptake studies showed that the studied complexes possess marked membrane permeability, pointing to high potential as anticancer therapeutics.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.70519","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149134471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
pH-Responsive Covalent Organic Framework-based Nanocarrier for Targeted Delivery of Cancer Therapeutics ph响应共价有机框架纳米载体靶向递送癌症治疗药物。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-08 DOI: 10.1002/cmdc.70527
Sukanya Bhunia, Kaivalya A. Deo, Manish K. Jaiswal
{"title":"pH-Responsive Covalent Organic Framework-based Nanocarrier for Targeted Delivery of Cancer Therapeutics","authors":"Sukanya Bhunia,&nbsp;Kaivalya A. Deo,&nbsp;Manish K. Jaiswal","doi":"10.1002/cmdc.70527","DOIUrl":"10.1002/cmdc.70527","url":null,"abstract":"<p>Covalent organic frameworks (COFs) are an emerging class of porous organic polymers with a broad spectrum of possible applications because of their large void spaces and modular pores. Despite excellent cytocompatibility, porosity, and biodegradability of COFs, their practical implementations in nanomedicine have been limited due to low water dispersibility and poor processability into nanodimensions. There are limited reports on nanoscale covalent organic frameworks, which can exhibit excellent drug loading capacity and pH-responsive drug release. Herein, a water-dispersible 2D COF-based nanocarrier is reported for pH-responsive targeted delivery of therapeutics (doxorubicin) to cancer cells. Particularly, a hydrolytically susceptible boronate ester-based covalent organic framework (COF-5) is supramolecularly stabilized with an amphiphilic polymer, Pluronic F127 (PLU), to obtain COF-PLU nanoparticles with a size of ~185 nm and a thickness of ~25 nm. A high doxorubicin loading in the COF-based nanocarrier (&gt;90% drug loading efficiency and ~35% drug loading capacity) and pH-responsive drug release are observed. Furthermore, the surface modification of Dox-loaded polymer-stabilized COF-5 with hyaluronic acid demonstrates selective delivery of doxorubicin to cancer cells. Our study demonstrates a facile strategy for developing a pH-responsive COF-based nanocarrier with excellent drug-loading capacity for targeted delivery of therapeutics to cancer cells.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149134484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis, Antiparasitic Activity, and ADME Profile of Morpholinephenylbenzamides: A Pharmacological Study Against Chagas Disease and Visceral Leishmaniasis Morpholinephenylbenzamides的合成、抗寄生虫活性和ADME谱:恰加斯病和内脏利什曼病的药理研究。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-08 DOI: 10.1002/cmdc.70518
Danilo Nascimento Farago, Daniela de Melo Resende, Mariza Gabriela Faleiro de Moura Lodi Cruz, Rafaela Marçal Sousa, Rafael Consolin Chelucci, Simone Michelan-Duarte, Felipe da Silva Mendonça de Melo, Douglas Davison da Silva Oliveira, Paula Derksen Macruz, Alexandra Maria dos Santos Carvalho, Eduardo Jorge Pilau, Izabela Marques Dourado Bastos, Adriano D. Andricopulo, Leonardo L. G. Ferreira, Silvane Maria Fonseca Murta, Celso de Oliveira Rezende Júnior
{"title":"Synthesis, Antiparasitic Activity, and ADME Profile of Morpholinephenylbenzamides: A Pharmacological Study Against Chagas Disease and Visceral Leishmaniasis","authors":"Danilo Nascimento Farago,&nbsp;Daniela de Melo Resende,&nbsp;Mariza Gabriela Faleiro de Moura Lodi Cruz,&nbsp;Rafaela Marçal Sousa,&nbsp;Rafael Consolin Chelucci,&nbsp;Simone Michelan-Duarte,&nbsp;Felipe da Silva Mendonça de Melo,&nbsp;Douglas Davison da Silva Oliveira,&nbsp;Paula Derksen Macruz,&nbsp;Alexandra Maria dos Santos Carvalho,&nbsp;Eduardo Jorge Pilau,&nbsp;Izabela Marques Dourado Bastos,&nbsp;Adriano D. Andricopulo,&nbsp;Leonardo L. G. Ferreira,&nbsp;Silvane Maria Fonseca Murta,&nbsp;Celso de Oliveira Rezende Júnior","doi":"10.1002/cmdc.70518","DOIUrl":"10.1002/cmdc.70518","url":null,"abstract":"<p>Chagas disease and leishmaniasis are neglected tropical diseases with limited treatment options. This study reports a hit-to-lead optimization of morpholinephenylbenzamides, starting from hit <b>1</b>, which showed potent activity against <i>Trypanosoma cruzi</i> (IC<sub>50</sub> 0.29–0.76 μM) and <i>Leishmania infantum</i> (IC<sub>50</sub> 10.7 μM), despite a suboptimal ADME profile. A structure–activity relationship study of twenty-four novel derivatives provided key pharmacophoric insights. While <i>Trypanosoma cruzi</i> was less susceptible to chemical modifications, compound <b>20</b> exhibited potency comparable to benznidazole (IC<sub>50</sub> 3.58 μM) with significantly improved selectivity, lipophilicity, and solubility relative to compound <b>1</b>. Against <i>Leishmania infantum</i>, six derivatives maintained activity, with compound <b>24</b> showing a 1.5-fold potency increase IC<sub>50</sub> 7.6 μM). Additionally, compound <b>16</b> stood out for its superior ADME profile, including enhanced permeability and metabolic stability. These findings validate the morpholinephenylbenzamide scaffold as a robust class with dual antiparasitic activity.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.70518","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149134550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scaffold Hopping Provides Liver X Receptor Agonist With Preference for the β Subtype 支架跳跃提供肝脏X受体激动剂对β亚型的偏好。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-07 DOI: 10.1002/cmdc.70509
Annette Kärcher, Fiona L. Motel, Felix F. Lillich, Astrid Kaiser, Ewgenij Proschak, Pascal Heitel
{"title":"Scaffold Hopping Provides Liver X Receptor Agonist With Preference for the β Subtype","authors":"Annette Kärcher,&nbsp;Fiona L. Motel,&nbsp;Felix F. Lillich,&nbsp;Astrid Kaiser,&nbsp;Ewgenij Proschak,&nbsp;Pascal Heitel","doi":"10.1002/cmdc.70509","DOIUrl":"10.1002/cmdc.70509","url":null,"abstract":"<p>The liver X receptor is a promising target for diseases with dysregulated cholesterol levels. In addition to enhanced reverse cholesterol transport, however, LXR activation induces hepatic lipogenesis. Since the subtype LXRα is dominant in the liver, one strategy to overcome this is the development of LXRβ-selective agonists. We optimized the reported compound <b>2</b> with efficacy-based preference for LXRβ by scaffold hopping to enhance potency and selectivity. Among the four different scaffolds, which were obtained from computer-assisted design and subsequent synthesis, compound <b>7</b> emerged as the most promising scaffold. The spiro[indan-1,4′-piperidine] scaffold of <b>7</b> demonstrated superior pharmacokinetic and pharmacodynamic properties, warranting its further investigation towards a pharmacological tool compound.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.70509","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149126359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polarity-Driven Scaffold Optimization of Diaryl Ether FabV Inhibitors to Enhance Aqueous Solubility 极性驱动支架优化二芳基醚FabV抑制剂提高水溶性。
IF 3.5 4区 医学
ChemMedChem Pub Date : 2026-10-07 DOI: 10.1002/cmdc.70512
Radu-George Bulai, Martina Parolini, Kara Anne Cummins, Sam Purnal, Eveline Lescrinier, Jef Rozenski, Joleen Masschelein, Peter Verwilst
{"title":"Polarity-Driven Scaffold Optimization of Diaryl Ether FabV Inhibitors to Enhance Aqueous Solubility","authors":"Radu-George Bulai,&nbsp;Martina Parolini,&nbsp;Kara Anne Cummins,&nbsp;Sam Purnal,&nbsp;Eveline Lescrinier,&nbsp;Jef Rozenski,&nbsp;Joleen Masschelein,&nbsp;Peter Verwilst","doi":"10.1002/cmdc.70512","DOIUrl":"10.1002/cmdc.70512","url":null,"abstract":"<p>The continuous rise and spread of antimicrobial resistance poses a severe threat to global health and creates an urgent need for the development of new classes of antibiotics. One promising target is FabV, an enoyl-acyl carrier protein reductase that is crucial for the survival of certain pathogenic Gram-negative species such as the opportunistic nosocomial bacterium <i>P. aeruginosa</i>. Previously, our group investigated the structure–activity relationship of diaryl ether-based inhibitors of FabV and uncovered <i>p</i>-<i>N</i>,<i>N</i>-dimethylsulfamoyl phenyl substitution as a privileged motif, exemplified by compounds <b>1a</b> (IC<sub>50</sub> = 0.25 μM) and <b>1e</b> (IC<sub>50</sub> = 0.19 μM). In the present study, we explored skeletal modifications of the diaryl ether scaffold with the aim of improving aqueous solubility of the compounds while maintaining potent activity. Our efforts uncovered compound <b>6k</b> (IC<sub>50</sub> = 0.53 μM), in which the alkyl chain is replaced by a 3-cyanocyclobutyl group and which shows a fivefold increase in kinetic solubility compared to the parent compound <b>1a</b>. Similarly, benzene-to-pyridine replacement in the A-ring led to significant solubility gains with minimal loss of potency. These results showcase an effective strategy for optimizing solubility in inhibitors targeting enzymes with highly lipophilic natural substrates.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149126382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书